Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Van Gogh-extension: Idraparinux for Long-term Prevention of VTE
NCT00071279Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2003
- Primary completion
- Dec 2005
- Modality
- Small Molecules
- Countries
- 20
01
Overview
A Phase 3 trial of idraparinux in venous thromboembolism (VTE), sponsored by Sanofi. Started Nov 2003; status: completed.
02
Drugs
idraparinux
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00071279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00071279.